摘要:
The present invention is directed to an aptamer comprising or consisting of the nucleic acid sequence of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and/or a nucleic acid sequence being at least 80% identical to one of SEQ ID No. 1, 2 and 3 for use in therapy and/or diagnosis of autoimmune diseases, wherein the autoimmune disease is cardiomyopathy, dilated cardiomyopathy (DCM), peripartum cardiomyopathy (PPCM), idiopathic cardiomyopathy, Chagas' cardiomyopathy, Chagas' megacolon, Chagas' megaesophagus, Chagas' neuropathy, benign prostatic hyperplasia, scleroderma, psoriasis, Raynaud syndrome, pre-eclamsia, kidney allograft rejection, myocarditis, glaucoma, hypertension, pulmonary hypertension, malignant hypertension, and/or Alzheimer's disease.
摘要翻译:本发明涉及包含SEQ ID No.1,SEQ ID No.2,SEQ ID No.3和/或与SEQ ID No.1,SEQ ID No.2,SEQ ID No.3的核酸序列至少80%同一性的核酸序列或由SEQ ID NO: SEQ ID No.1,2和3用于治疗和/或诊断自身免疫疾病,其中自身免疫疾病是心肌病,扩张型心肌病(DCM),围产期心肌病(PPCM),特发性心肌病,恰加斯氏病,查加斯巨结肠 ,查加斯巨大食管,恰加斯神经病,良性前列腺增生症,硬皮病,牛皮癣,雷诺综合征,前风疹,肾同种异体移植排斥,心肌炎,青光眼,高血压,肺动脉高压,恶性高血压和/或阿尔茨海默病。
摘要:
The present invention is directed to an aptamer comprising or consisting of the nucleic acid sequence of SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3 and/or a nucleic acid sequence being at least 80% identical to one of SEQ ID No. 1, 2 and 3 for use in therapy and/or diagnosis of autoimmune diseases, wherein the autoimmune disease is cardiomyopathy, dilated cardiomyopathy (DCM), peripartum cardiomyopathy (PPCM), idiopathic cardiomyopathy, Chagas' cardiomyopathy, Chagas' megacolon, Chagas' megaesophagus, Chagas' neuropathy, benign prostatic hyperplasia, scleroderma, psoriasis, Raynaud syndrome, pre-eclamsia, kidney allograft rejection, myocarditis, glaucoma, hypertension, pulmonary hypertension, malignant hypertension, and/or Alzheimer's disease.
摘要翻译:本发明涉及包含SEQ ID No.1,SEQ ID No.2,SEQ ID No.3和/或与SEQ ID No.1,SEQ ID No.2,SEQ ID No.3的核酸序列至少80%同一性的核酸序列或由SEQ ID NO: SEQ ID No.1,2和3用于治疗和/或诊断自身免疫疾病,其中自身免疫疾病是心肌病,扩张型心肌病(DCM),围产期心肌病(PPCM),特发性心肌病,恰加斯氏病,查加斯巨结肠 ,查加斯巨大食管,恰加斯神经病,良性前列腺增生症,硬皮病,牛皮癣,雷诺综合征,前风疹,肾同种异体移植排斥,心肌炎,青光眼,高血压,肺动脉高压,恶性高血压和/或阿尔茨海默病。
摘要:
The invention relates to a method for improving transfection efficiency through the use of K16-peptides. In addition, the invention further relates to novel K16-peptides, including a K16-CYC peptide.